drugset / Trial / NCT00004008

Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer

NCT00004008

Phase 2 Completed University of Glasgow
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have ovarian epithelial cancer that has not responded to previous chemotherapy.

Timeline

Start
1999-07
Primary completion
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject bryostatin 1 Small molecule Intravenous

Indications